Cabot (NYSE:CBT) Upgraded by Wall Street Zen to Buy Rating

Cabot (NYSE:CBT) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Sunday.

CBT has been the subject of several other reports. JPMorgan Chase & Co. lifted their price objective on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a report on Wednesday, May 13th. UBS Group boosted their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research report on Friday, May 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Mizuho upped their target price on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Finally, Truist Financial began coverage on Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price target for the company. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $83.80.

Cabot Trading Up 2.5%

CBT opened at $87.63 on Friday. The business’s 50 day moving average is $80.10 and its two-hundred day moving average is $73.86. Cabot has a 52 week low of $58.33 and a 52 week high of $89.46. The firm has a market cap of $4.52 billion, a price-to-earnings ratio of 16.57, a price-to-earnings-growth ratio of 11.53 and a beta of 0.82. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last announced its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. During the same period last year, the business posted $1.90 EPS. The company’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, research analysts predict that Cabot will post 6.34 EPS for the current year.

Hedge Funds Weigh In On Cabot

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. NewEdge Advisors LLC lifted its holdings in shares of Cabot by 2,559.5% in the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock valued at $82,000 after purchasing an additional 947 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Cabot by 32.5% in the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after purchasing an additional 108,645 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of Cabot by 102.6% in the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after purchasing an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Cabot by 3.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after purchasing an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares in the last quarter. 93.18% of the stock is owned by institutional investors.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.